V. Gounant

6.0k total citations
133 papers, 1.6k citations indexed

About

V. Gounant is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, V. Gounant has authored 133 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Pulmonary and Respiratory Medicine, 71 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in V. Gounant's work include Lung Cancer Treatments and Mutations (62 papers), Lung Cancer Diagnosis and Treatment (37 papers) and Lung Cancer Research Studies (29 papers). V. Gounant is often cited by papers focused on Lung Cancer Treatments and Mutations (62 papers), Lung Cancer Diagnosis and Treatment (37 papers) and Lung Cancer Research Studies (29 papers). V. Gounant collaborates with scholars based in France, Germany and United States. V. Gounant's co-authors include Gérard Zalcman, A. Lavolé, Solenn Brosseau, Jacques Cadranel, Antoine Khalil, Marie Wislez, B. Milleron, Sandra Assoun, Martine Antoine and Anne-Marie Ruppert and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

V. Gounant

118 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V. Gounant France	23	960	831	267	167	165	133	1.6k
Yuka Fujita Japan	21	1.2k 1.3×	1.2k 1.4×	321 1.2×	146 0.9×	280 1.7×	77	1.8k
Renata Langfort Poland	19	904 0.9×	594 0.7×	275 1.0×	162 1.0×	261 1.6×	145	1.6k
A. Lavolé France	24	897 0.9×	916 1.1×	135 0.5×	254 1.5×	81 0.5×	105	1.7k
John Wen‐Cheng Chang Taiwan	21	719 0.7×	931 1.1×	453 1.7×	113 0.7×	231 1.4×	95	1.6k
Dominick Bossé Canada	18	692 0.7×	908 1.1×	299 1.1×	195 1.2×	207 1.3×	71	1.5k
Helge Bischoff Germany	21	986 1.0×	873 1.1×	203 0.8×	336 2.0×	150 0.9×	62	1.6k
Niamh M. Long United States	13	687 0.7×	1.5k 1.7×	427 1.6×	173 1.0×	118 0.7×	22	2.0k
H. Léna France	20	1.7k 1.8×	1.2k 1.5×	300 1.1×	241 1.4×	234 1.4×	95	2.3k
Emily Z. Keung United States	23	868 0.9×	1.1k 1.3×	296 1.1×	150 0.9×	107 0.6×	73	1.8k
T V Colby United States	13	993 1.0×	665 0.8×	390 1.5×	219 1.3×	245 1.5×	18	1.8k

Countries citing papers authored by V. Gounant

Since Specialization

Citations

This map shows the geographic impact of V. Gounant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Gounant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Gounant more than expected).

Fields of papers citing papers by V. Gounant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Gounant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Gounant. The network helps show where V. Gounant may publish in the future.

Co-authorship network of co-authors of V. Gounant

This figure shows the co-authorship network connecting the top 25 collaborators of V. Gounant. A scholar is included among the top collaborators of V. Gounant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Gounant. V. Gounant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Levallet, Guénaëlle, Christian Créveuil, Solenn Brosseau, et al.. (2025). MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial. Translational Oncology. 61. 102520–102520. 1 indexed citations

Swalduz, Aurélie, I. Monnet, Florian Guisier, et al.. (2022). 995P Effectiveness of combination of osimertinib with another targeted therapy in advanced EGFR mutated non-small cell lung cancer harbouring other oncogenic drivers: The real-world COMPOSIT study. Annals of Oncology. 33. S1008–S1008.

Gounant, V., M. Duruisseaux, Olivier Bylicki, et al.. (2021). Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients. Cancers. 13(5). 1040–1040. 9 indexed citations

Mazieres, J., Pascale Tomasini, Amélie Lusque, et al.. (2020). 1279P Impact of KRAS mutations and subtypes on efficacy of immune-checkpoint inhibitors (ICI) in non-small cell lung cancer (NSCLC). Annals of Oncology. 31. S826–S827. 10 indexed citations

Cros, Jérôme, Nathalie Théou–Anton, V. Gounant, et al.. (2020). Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology. Neuroendocrinology. 111(1-2). 158–169. 32 indexed citations

Eberst, Guillaume, Amélie Anota, Arnaud Scherpereel, et al.. (2019). Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial. Clinical Cancer Research. 25(19). 5759–5765. 15 indexed citations

Assoun, Sandra, Nathalie Théou–Anton, Aurélie Cazes, et al.. (2019). Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer. Lung Cancer. 132. 65–71. 117 indexed citations

Pluvy, Johan, Solenn Brosseau, Claire Danel, et al.. (2019). Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report. BMC Pulmonary Medicine. 19(1). 12–12. 5 indexed citations

Ruppert, Anne-Marie, James M. Perrin, Antoine Khalil, et al.. (2018). Effect of cannabis and tobacco on emphysema in patients with spontaneous pneumothorax. Diagnostic and Interventional Imaging. 99(7-8). 465–471. 16 indexed citations

10.

Brosseau, Solenn, V. Gounant, Charles Naltet, et al.. (2017). Lazarus Syndrome With Crizotinib in a Non–Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation. Clinical Lung Cancer. 19(1). e57–e61. 4 indexed citations

11.

Khalil, Antoine, et al.. (2016). Contribution of magnetic resonance imaging in lung cancer imaging. Diagnostic and Interventional Imaging. 97(10). 991–1002. 29 indexed citations

12.

Gounant, V., Solenn Brosseau, Charles Naltet, et al.. (2016). Nivolumab-induced organizing pneumonitis in a patient with lung sarcomatoid carcinoma. Lung Cancer. 99. 162–165. 31 indexed citations

13.

Perkins, Géraldine, Elizabeth Fabre, Vincent Fallet, et al.. (2016). Whole exome sequencing (WES) and RNA sequencing (RNA-seq) in routine clinical practice for colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) patients (pts). Annals of Oncology. 27. vi29–vi29.

14.

Salaün, Mathieu, C. Chouaïd, V. Gounant, et al.. (2013). Cost-effectiveness of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for the preoperative staging of lung cancer, results from the French prospective multicenter trial "EVIEPEB". European Respiratory Journal. 42(Suppl 57). 1997–1997.

15.

Ruppert, Anne-Marie, Julie Fillon, A. Lavolé, et al.. (2011). Skin Toxicities Compromise Prolonged Pemetrexed Treatment. Journal of Thoracic Oncology. 6(12). 2083–2089. 28 indexed citations

16.

Giroux‐Leprieur, Etienne, A. Lavolé, Anne-Marie Ruppert, et al.. (2011). Factors associated with long‐term survival of patients with advanced non‐small cell lung cancer. Respirology. 17(1). 134–142. 42 indexed citations

17.

Gounant, V., B. Milleron, Jalal Assouad, et al.. (2009). Bevacizumab et actes invasifs : recommandations pratiques. Revue des Maladies Respiratoires. 26(2). 221–226. 5 indexed citations

18.

Gauler, Thomas, Benjamin Besse, Jean‐Baptiste Méric, et al.. (2007). C1-01: Phase II open-label study to investigate PTK787/ZK 222584 (PTK/ZK) orally administered as a second-line monotherapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). Journal of Thoracic Oncology. 2(8). S358–S358. 2 indexed citations

19.

Cadranel, Jacques, Marie Wislez, V. Gounant, et al.. (2007). Prise en charge thérapeutique des adénocarcinomes de type bronchiolo-alvéolaires étendus : chimiothérapie ou inhibiteurs de la tyrosine kinase du récepteur de l’epidermal growth factor ?. Revue de Pneumologie Clinique. 63(3). 147–154. 1 indexed citations

20.

Milleron, B., Nicolas Girard, V. Gounant, & F. Mornex. (2006). La chimioradiothérapie préopératoire des cancers bronchiques non à petites cellules. Cancer/Radiothérapie. 11(1-2). 36–40.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact